Press Center

We invite you to a webinar on antitrust risks for pharmaceutical companies when setting prices for medicinal products.

On May 26, Moscow will host the XVII Antitrust Forum — the flagship event in Russian competition law. The forum is traditionally held with the support of the Federal Antimonopoly Service of Russia (FAS Russia) and the Association of Antimonopoly Experts (AAE). This year’s main theme is competition in the digital economy.

Lidings is an official partner of the forum and is organising a special session: “Pharmaceuticals & Antitrust: The Fight for Fair Competition Amid Economic Challenges.”

April 9^th,2026 annual conference Pharmaceuticals – 2026: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2025 and what awaits us in 2026.

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.

On February 17, 2026, the annual flagship seminar of Lidings, "Predictions 2026: Crystal Clarity Instead of Legal Fog," was held at the Hotel Metropol.

The event marked the beginning of a series of celebrations dedicated to the firm's 20th anniversary and brought together over 70 representatives from 50 Russian and international companies.

Lidings' lawyers together with invited speakers from the corporate sector discussed key legislative changes and shared current trends and practical tools.

2026 is a special year for our team — it marks our 20th anniversary. And we are especially pleased to kick it off with a seminar where we will look into the "Crystal of Predictions": back to the past — to review the key legal developments of the past year, and forward to the future — to share crystal-clear insights on the key business trends awaiting in 2026.

On 2 February 2024, the Online Safety Act, No. 9 of 2024 (hereinafter referred to as the “OSA”) was officially published in Sri Lanka. The OSA is a significant and controversial element of information security regulation in Sri Lanka. It establishes provisions prohibiting the communication of prohibited statements online and aims to prevent the use of online accounts and inauthentic online accounts for prohibited purposes.

On January 16, 2026, as part of the Lidings Global – Indian Desk project, the expert webinar "Opportunities for Indian Medical Device Manufacturers in the Russian Market" took place. The event was organized by Lidings in cooperation with the Association of Indian Manufacturers of Medical Devices (AiMeD) and the LexCounsel Law Offices. The webinar was designed exclusively for AiMeD member companies, targeting senior management, specialists from manufacturing firms, and industry experts.